27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Prior to the report, Sabra Health Care REIT Inc (NASDAQ: SBRA) just completed a 5.9 million share secondary offering at $25.25 per share, raising ~$149 million to fund recent acquisitions and pay down revolving debt.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Sabra owns 169 properties, including 103 skilled nursing facilities, 64 senior housing facilities and two acute care hospitals. The properties contain a total of 17,593 beds/units and are located in 34 states.
This makes $1.5 billion cap Sabra one of the smaller healthcare (HC) REITs, along with peers:
- National Health Investors Inc (NYSE: NHI): $2.4 billion cap, 5.5 percent yield
- LTC Properties Inc (NYSE: LTC): $1.5 billion cap, 4.9 percent yield
- Omega Healthcare Investors Inc (NYSE: OHI): $6.3 billion cap, 6.3 percent yield
Tale Of The Tape: 2015 Front Half
Stifel noted that Sabra was trading at ~11x 2015E FAD (funds available for distribution), a measure of REIT cash flow often referred to as AFFO.
This compared favorably to a 2015E peer average of 15x, with National Health Investors, LTC and Omega Healthcare Investors trading at about 15x, 16.8x and 12.5x, respectively.
Stifel–SBRA: Buy Rated, PT Reduced From $33 To $30
The new Stifel $30 target price represents a potential ~16.5 percent share price upside based on Tuesday's close of $25.74 per share.The Sabra $30 PT was based upon a 13x Price/FAD multiple, (still lower than peer average); which also values the shares "at an implied cap rate of 6.75 percent on forward NOI."
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
Stifel believes based on Sabra's "current leverage and portfolio mix, SBRA should at a discount to peers;" however, the current 4x discount is excessive and represents a value opportunity for investors.
Stifel–SBRA Rationale
- Stifel believes this is a positive for growing NOI, "as SNF investments typically yield 250–350bps higher than seniors housing."
Stifel–SBRA Risk Factors
Key risks included:
- 1. "Sabra's significant concentration of its assets in skilled nursing and its reliance on one operator, Genesis HealthCare, for approximately 30 percent of net operating income."
- 2. Stifel assumes "that Sabra is able to execute on accretive acquisitions to help build FFO and FAD."
- 3. The likelihood "of future equity share issuance to fund Sabra's investment activity."
Stifel–SBRA Bottom Line
Vanacore and Bernstein believe that Sabra Health Care REIT represents "a compelling value play."
The current 6 percent dividend yield, combined with the 16.5 percent target price appreciation, represents a potential total 12 month investor return of 22.5 percent.
Image Credit: Public Domain27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.